Research theme 2
Theme Lead: Professor Amit Nathwani
Senior researchers within the BTRU in Stem Cells and Immunotherapies have extensive experience relating to genetic modification of both stem cells and of T-cells in order to correct genetic defects or enhance anti-tumour activity respectively. We aim to use this knowledge and experience to refine strategies to treat inherited genetic disorders by investigating improved vector design and evaluating alternative gene editing technologies - examining their potential to influence the activity of target genes, and, modify T-cell behaviour. Further work will focus on advances in chimeric antigen receptor (CAR) T-cell therapies and crosses over with Research Theme 3.